Use of disease risk scores in pharmacoepidemiologic studies

被引:106
|
作者
Arbogast, Patrick G. [1 ]
Ray, Wayne A. [2 ,3 ]
机构
[1] Vanderbilt Univ, Dept Biostat, Nashville, TN 37232 USA
[2] Vanderbilt Univ, Dept Prevent Med, Nashville, TN 37232 USA
[3] Nashville Vet Adm, Med Ctr, Ctr Geriatr Res Educ & Clin, Nashville, TN 37232 USA
基金
美国医疗保健研究与质量局;
关键词
NONSTEROIDAL ANTIINFLAMMATORY DRUGS; PROPENSITY SCORE; STRATIFICATION; DEATH;
D O I
10.1177/0962280208092347
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Automated databases are increasingly used in pharmacoepidemiologic studies. These databases include records of prescribed medications and encounters with medical care providers from which one can construct very detailed Surrogate measures for both drug exposure and covariates that are potential confounders. Often it is possible to track day-by-day changes in these variables. However, while this information is often critical for study success, its Volume can pose challenges for statistical analysis. One common approach is the use of propensity scores. An alternative approach is to construct a disease risk score. This is analogous to the propensity score in that it calculates a summary measure from the covariates. However, the disease risk score estimates the probability or rate of disease Occurrence conditional oil being unexposed. The association between exposure and disease is then estimated adjusting for the disease risk score in place of the individual covariates. This review describes the use of disease risk scores in phamacoepidemiologic studies, and includes a brief discussion of their history, a more detailed description of their construction and use, a summary of simulation Studies comparing their performance vis-a-vis traditional models, a comparison of their utility with that of propensity scores, and some further topics for future research.
引用
收藏
页码:67 / 80
页数:14
相关论文
共 50 条
  • [41] Systemic conditions for performance of pharmacoepidemiologic studies in Slovenia
    Primozic, S
    Kos, M
    Mrhar, A
    Ravnik, I
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2001, 10 (07) : 675 - 678
  • [42] Sequence symmetry analysis in pharmacovigilance and pharmacoepidemiologic studies
    Edward Chia-Cheng Lai
    Nicole Pratt
    Cheng-Yang Hsieh
    Swu-Jane Lin
    Anton Pottegård
    Elizabeth E. Roughead
    Yea-Huei Kao Yang
    Jesper Hallas
    European Journal of Epidemiology, 2017, 32 : 567 - 582
  • [43] Chronic renal disease is not chronic kidney disease: implications for use of the QRISK and Joint British Societies risk scores
    Stevens, Sarah L.
    Stevens, Richard J.
    Hobbs, F. D. Richard
    Lasserson, Daniel S.
    FAMILY PRACTICE, 2016, 33 (01) : 57 - 60
  • [44] Bayesian propensity score analysis for pharmacoepidemiologic studies
    McCandless, C.
    Gustafson, P.
    Austin, P. C.
    EUROPEAN JOURNAL OF EPIDEMIOLOGY, 2006, 21 : 38 - 38
  • [45] Using Pharmacoepidemiologic Studies to Inform Drug Policy
    Knowles, Sandra
    Tadrous, Mina
    Martins, Diana
    Gomes, Tara
    Juurlink, David
    Mamdani, Muhammad
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2015, 24 : 14 - 15
  • [46] Genome-Wide Association Studies and Risk Scores for Coronary Artery Disease: Sex Biases
    Byars, Sean G.
    Inouye, Mike
    SEX-SPECIFIC ANALYSIS OF CARDIOVASCULAR FUNCTION, 2018, 1065 : 627 - 642
  • [47] Concept, Measurement and Use of Acculturation in Health and Disease Risk Studies
    Chakraborty, Bandana M.
    Chakraborty, Ranajit
    COLLEGIUM ANTROPOLOGICUM, 2010, 34 (04) : 1179 - 1191
  • [48] Risk Scores in Valvular Heart Disease Interventions
    Casalino, Ricardo
    Tarassoutchi, Flavio
    ARQUIVOS BRASILEIROS DE CARDIOLOGIA, 2012, 98 (05) : E84 - E86
  • [49] Polygenic risk scores in coronary artery disease
    Christiansen, Morten Krogh
    Nyegaard, Mette
    Jensen, Henrik Kjaerulf
    CURRENT OPINION IN CARDIOLOGY, 2023, 38 (01) : 39 - 46
  • [50] Cardiovascular Disease Risk Prediction Models and Scores
    Giannakoulas, George
    Doundoulakis, Ioannis
    CURRENT PHARMACEUTICAL DESIGN, 2021, 27 (10) : 1231 - 1231